Interferon beta-1a

Preferred Label : Interferon beta-1a;

MeSH definition : An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.;

MeSH synonym : beta-1a, Interferon; Interferon beta 1a; beta 1a, Interferon;

CISMeF synonym : 1a, Interferon beta; Avonex Pen; Pen, Avonex;

MeSH hyponym : rebif; avonex;

MeSH Related Number : 145258-61-3; 74899-71-1;

Wikipedia link : https://en.wikipedia.org/wiki/Interferon beta 1a;

Is substance : O;

UNII : XRO4566Q4R;

Details

Origin ID

D000068556;

UMLS CUI

C0254119;

ATC code(s)
- interferon beta-1a [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Avon (geographic location) [SNOMED CT concept]
- Interferon beta-1a [ICD-11 Extension code]
CISMeF manual mappings
- Interferon Beta-1A [NCIt concept]
- Interferon beta-1a (substance) [SNOMED CT concept]
Pharmacological action(s)
- adjuvants, immunologic [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- antiviral agents [MeSH Descriptor]
Record concept(s)
- Avonex Pen [MeSH concept]
- Interferon beta-1a [MeSH concept]
- avonex [MeSH concept]
- rebif [MeSH concept]
Related MeSH Supplementary Concept(s)
- sampeginterferon beta-1a [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Interferon beta-1a (substance) [SNOMED CT concept]
- Interferon.beta 1a [LOINC component]
- Product containing interferon beta-1a (medicinal product) [SNOMED CT concept]
- interferon beta-1a [ATC Code]
Validated automatic mappings to BTNT
- interferon beta-1a [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients